Indemakitug

N/A

Report date: 2025/11/04 20:00:06

Base Information

Drug NameIndemakitug
Drug Alias NameEI-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterferon gamma inhibitors
TargetsInterferon gamma
Therapy Area/IndicationsVitiligo
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesElixiron Immunotherapeutics Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgElixiron Immunotherapeutics (Shanghai) LtdElixiron Immunotherapeutics (Hong Kong) Ltd
Inactive CompaniesN/A
Active IndicationsVitiligo
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A